https://www.publichealth.columbia.edu/about/board-advisors
CHELSEA CLINTON
As Vice-Chair of the Clinton Foundation, Dr. Chelsea Clinton works alongside the Foundation’s leadership and partners to help create economic opportunity, improve public health, and inspire civic engagement and service across the United States and around the world. In particular, Chelsea focuses on promoting early brain and language development through the Too Small to Fail initiative, and uplifting/empowering female entrepreneurs and women-led businesses around the world through initiatives like the Caribbean-focused Women in Renewable Energy (WIRE) Network. She also serves on the boards of the Clinton Health Access Initiative and the Alliance for a Healthier Generation. In addition to her Foundation work, Chelsea also teaches at Columbia University Mailman School of Public Health and has written several books for young readers, including the #1 New York Times bestselling She Persisted: 13 American Women Who Changed the World, as well as She Persisted Around the World, She Persisted in Sports, Start Now! You Can Make a Difference; Don’t Let Them Disappear, and It’s Your World: Get Informed, Get Inspired & Get Going. She is also the co-author of The Book of Gutsy Women and Grandma’s Gardens with her mom Hillary Clinton and of Governing Global Health: Who Runs the World and Why? with Devi Sridhar. Chelsea holds a Bachelor of Arts from Stanford, a Master of Public Health from Columbia University Mailman School of Public Health, and both a Master of Philosophy and a Doctorate in international relations from Oxford University. She lives with her husband Marc, their children Charlotte, Aidan and Jasper, and dog Soren in New York City.
ALAN BATKIN
Alan R. Batkin was Vice Chairman of Eton Park Capital Management, L.P., a global, multi-disciplinary investment firm from 2007 to 2012. Prior to joining Eton Park, he was, from 1990 to 2007, Vice Chairman of Kissinger Associates, a geopolitical consulting company. He is Chairman Emeritus of the International Rescue Committee; Chair of Airbel, IRC’s Innovation Lab; a Trustee and member of the Executive Committee of the New York City Police Foundation; a member of the Board and Executive Committee of the MD Anderson Cancer Center and Chair of the Massachusetts General Hospital Center for Global Health. He is a member of the Columbia Zuckerman Mind Brain Behavior Institute’s “Brain Trust”. Mr. Batkin is a Trustee of The Brookings Institution and a member of the Council on Foreign Relations and a former member of The Trilateral Commission and the Inter-American Dialogue. He received a BS from the University of Rochester and an MBA from NYU.
DINA DUBLON
Ms. Dina Dublon is a board member of PepsiCo and TRowe Price Group and is a member of IAQC at EY US. She is co-chair of Columbia University, Herbert Irving Cancer Center Advisory Council, and a member of Columbia University Mailman School of Public Health’s Board of Advisors. She served on the supervisory board of Deutsche Bank 2013-2018 and on the boards of Accenture 2002-2017 and Microsoft 2005-2014 and was on the faculty of Harvard Business School in 2011-12. She was co-chair of the Women’s Refugee Commission and on the board of Global Fund for Women. Ms. Dublon was until the end of 2004 EVP and CFO of JPMorgan Chase, responsible for global financial management and related operations, strategy and acquisitions, corporate treasury, tax, and investor relations. She played a key role in negotiations and merger integration of Chemical Bank with Manufacturers Hanover, Chase, JPMorgan, and Bank One.
DINA SAID DWYER
Dina Said Dwyer is the Managing Director of Eden capital, a PE firm focused in the professional & business services, education & training, and healthcare services sectors. Ms. Said has spent over 20 years in the private equity industry. She has served as a managing director at Unifund SA, an Analyst at the Blackstone Group in New York, and trained at the Carlyle Group in London. She also currently leads Brighter Vision, her family Foundation, dedicated to providing education and economic empowerment to women in Egypt through partnerships with Ashoka, Education for Employment, and other prominent groups and sits on the Advisory Board of the Children’s Rights Division for Human Rights Watch. Ms. Said completed her MBA at Columbia Business School and her undergraduate degree at the Wharton School of Business.
XUE FANG
Dr. Xue Fang is currently a member of the President’s Advisory Council and a member of the Graduate School Dean’s Leadership Council of Princeton University. She also serves as a director in Teach for China, Inc. Born in Beijing, China, Xue studied Biology at Beijing University before attending the Graduate School of Princeton University in 1988 to study Neuroscience. She received a Ph.D. in Neuroscience and Psychology in 1995 from Princeton University and an MS in Biostatistics from Columbia University Mailman School of Public Health in 1998. She has participated in medical research projects and has worked as a biostatistician in Schering-Plough, a pharmaceutical company in New Jersey. Xue has a special interest in education and enjoys reading extensively.
ADRIAN GORE
South African Adrian Gore is the founder and Chief Executive Officer of Discovery, a multinational financial services group. Discovery is a global thought leader in consumer-driven insurance and the integration of behavioral change with health and life and short-term insurance. It serves over six million customers worldwide. Mr. Gore chairs the South African chapter of Endeavor, a global non-profit organization that identifies and assists high-growth entrepreneurs. He sits on the World Economic Forum Global Health Advisory Board, which is committed to improving global healthcare, the Brookings Advisory Board, and on the Massachusetts General Hospital Global Health Advisory Board. Mr. Gore graduated from Wits University in 1986.
FRANK JIMENEZ
Frank R. Jimenez leads the Office of General Counsel of Raytheon Technologies, where he oversees a variety of legal and regulatory affairs, including corporate governance and transactions, ethics and compliance, litigation, contracts, and intellectual property. His career includes legal leadership positions in military agencies, civil government, and public companies in the private sector. Most recently he was vice president, general counsel, and corporate secretary of Raytheon Company prior to its merger with United Technologies Corporation in 2020. Jimenez previously served as general counsel of three S&P 500 Companies: ITT Corp., Xylem Inc., and Bunge Ltd. Before that, he served as the 21st General Counsel of the Navy, where he was one of seven Senate-confirmed Pentagon civilians of four-star equivalent rank overseeing the U.S. Navy and Marine Corps. He was also the deputy general counsel for the U.S. Department of Defense, chief of staff at the U.S. Department of Housing and Urban Development, and deputy chief of staff and acting general counsel to the governor of Florida. He holds a Bachelor’s degree from the University of Miami, a Juris Doctorate degree from the Yale Law School, an MBA from the Wharton School at the University of Pennsylvania, and a master’s degree in national security and strategic studies from the U.S. Naval War College.
ANN KAPLAN
Ann Kaplan is a partner of Circle Wealth Management, a registered financial advisory firm, focusing on wealth management. She is also the chair and founder of Circle Financial Group, an investment management membership group. She taught asset management at Columbia Business School prior to becoming a University Trustee. Ms. Kaplan was previously a general partner of Goldman, Sachs & Co. She currently serves on the board of the Goldman Sachs Bank USA. Ms. Kaplan is a Columbia University Trustee Emerita. She serves on the Board of Advisors of the Columbia University School of Business and the Board of Advisors at the Medical Center. She is Chair of the Women Creating Change Leadership Board. Ms. Kaplan also serves as a board member of the American Red Cross in Greater New York and the Museum of Arts and Design. She is a member of the Council on Foreign Relations, the Economic Club of New York, the Belizean Grove, and the International Women’s Forum. Ms. Kaplan holds a B.A. from Smith College and an M.B.A. from Columbia University.
DAVID MAGSTADT
Dave Magstadt is a Senior Managing Director and founding member of the Medical Device practice at Guggenheim Securities (“Guggenheim”), the investment banking and capital markets business of Guggenheim Partners. Guggenheim is a leading, independent, and global investment banking firm focused in providing advisory, capital markets, sales, and trading and research to institutional clients. Mr. Magstadt joined the firm in July 2015 to lead the medical device mergers and acquisitions execution effort with the group. Prior to joining Guggenheim, Dave spent 12 years at Citigroup Global Markets Inc. working in the global mergers and acquisitions group in New York focused on Healthcare. Over the course of his career, Mr. Magstadt has advised on a broad range of public and private corporate transactions in the hundreds of billions of deal value. Dave earned a Masters of Business Administration with Honors at Columbia in 2003 and spent three years prior to business school as a consultant at Accenture both in the US and Europe. He holds a Bachelor of Science in Biochemistry from the University of Oklahoma, where he graduated Phi Beta Kappa and was honored as one of the 10 most outstanding students at the university. He has served on the Junior Board of the New York chapter of Covenant House and is an alumnus of Haymakers for Hope.
>https://www.publichealth.columbia.edu/about/board-advisors
DIANA TAYLOR
Diana Taylor is currently Vice-Chair of Solera Capital, LLC. She previously served as managing director at Wolfensohn Fund Management L.P., a strategic consulting and investment firm. Prior to Wolfensohn, she served as New York State superintendent of banks and chairwoman of the New York State Banking Board. Before her government service, she worked in the private sector as vice president for KeySpan Energy and as an investment banker with Smith Barney, Lehman Brothers, and Donaldson Lufkin & Jenrette. Ms. Taylor serves on the boards of Citigroup, Brookfield Asset Management, and Sotheby’s. She also serves on several charitable boards. She chairs the boards of Accion and Hudson River Park Trust. Other board memberships include the New York Women’s Foundation, the YMCA of Greater New York, Dartmouth College, the International Women’s Health Coalition, and the Mayo Clinic. She is also a member of the Council on Foreign Relations and the Economic Club of New York. She earned her BA from Dartmouth College, her MBA from Columbia School of Business, and her MPH from the Columbia University Mailman School of Public Health.
ASHWIN VASAN
(Ex-Officio Member): Dr. Ashwin Vasan is the Commissioner of the New York City Department of Health and Mental Hygiene. Dr. Vasan is a primary care physician, epidemiologist and public health expert with nearly 20 years of experience working to improve physical and mental health, social welfare and public policy for marginalized populations here in New York City, nationally and globally. Since 2014 he has served on the faculty at the Columbia University Mailman School of Public Health and Vagelos College of Physicians and Surgeons, and he continues to see patients as a primary care internist in the Division of General Medicine at New York-Presbyterian Hospital/Columbia University Irving Medical Center. Dr. Vasan most recently served as the President and CEO of Fountain House, a national nonprofit fighting to improve health, increase opportunity, and end social and economic isolation for people most impacted by mental illness. Early in his career, Dr. Vasan spent nearly a decade at the intersection of global health, HIV and primary care, working with the nonprofit Partners In Health (PIH) in Rwanda, Lesotho and Boston, and at the World Health Organization (WHO) in Uganda and Geneva. From 2016 to 2019, Dr. Vasan served as the founding Executive Director of the Health Access Equity Unit at the NYC Department of Health and Mental Hygiene, which focused on the intersection of clinical and social services for the care of people involved in the justice system and other vulnerable populations. He is a proud husband and father of three school-aged children who fill up every free moment of his time.
IAN WOO
Ian Woo is a Managing Director at C-Bridge Capital, a healthcare dedicated private equity firm focused on growth and late-stage investment opportunities with $1.7 billion under management. Ian is also the President & CFO of Everest Medicines, a biopharma platform started by C-Bridge Capital that is focused on bringing innovative medicines to Great China and Asia emerging markets across four therapeutic areas: Oncology, Infectious Disease, Renal & Immunology, and CNS. Previously, Ian was a managing director in the global healthcare group at Lazard, one of the world's premier financial advisory and asset management firms. He worked with numerous global biopharma companies and led Lazard’s healthcare efforts in Greater China. Ian joined Lazard in 2005 and was based in New York, other than from 2012 to 2016, when he worked in the firm’s Hong Kong office. Ian holds a Master of Business Administration from Columbia University Business School, a Master’s degree in Molecular and Cellular Biology from Columbia University Graduate School of Arts & Sciences, and a Bachelor’s degree in Biology from Tufts University. Ian was also a student at Harvard University Graduate School of Arts & Sciences and conducted research at Harvard Medical School and Brigham and Women’s Hospital, where he was an author on multiple published papers.